AS

Adi Sesha Giri Jagarapu

Active Director Director DIN 08774486
DIN 08774486 First appointment Jun 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jun 2020
Shareholding value •••• Premium profile

About Adi Sesha Giri Jagarapu

Data last updated:

Adi Sesha Giri Jagarapu is a Director at Hetero Drugs Limited (since 2021), Director at Honour Lab Limited (since 2023) and Director at Ojas Pharmaceuticals Private Limited (since 2020). The companies operate in Pharma and Manufacturing. The 2 current companies with reported revenue have a combined latest revenue of ₹5,807 Cr; the largest is Hetero Drugs Limited at ₹3,324 Cr (FY 2025). Earlier, Adi Sesha Giri Jagarapu was an Additional Director at Degradable Polymer Technologies Private Limited (2020–2021).

DIN 08774486
Primary Designation Director
Industry Pharma
First Appointment 22 Jun 2020
Oldest Company Age 33 yrs
Largest company Hetero Drugs Limited · ₹3,324 Cr (FY 2025)
Combined revenue ₹5,807 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hetero Drugs Limited U24230TG1993PLC015582
Director23 Sep 20211993₹3,324 Cr (FY 2025)Active
Honour Lab Limited U24233TG2011PLC077561
Director18 Dec 20232011₹2,483 Cr (FY 2025)Active
Ojas Pharmaceuticals Private Limited U24230TG1993PTC016508
Director22 Jun 20201993Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 Jun 20202010₹28,895 (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Adi Sesha Giri Jagarapu

Directorship timeline

Open interactive timeline →
Hetero Drugs Limited
Ojas Pharmaceuticals Private Limited
Honour Lab Limited
Degradable Polymer Technologies Private Limited
Premium access

Shareholding and investment profile for Adi Sesha Giri Jagarapu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adi Sesha Giri Jagarapu

Adi Sesha Giri Jagarapu currently holds 3 directorships: Hetero Drugs Limited (Director, since 23 Sep 2021, revenue ₹3,324 Cr (FY 2025)); Honour Lab Limited (Director, since 18 Dec 2023, revenue ₹2,483 Cr (FY 2025)); Ojas Pharmaceuticals Private Limited (Director, since 22 Jun 2020).

Adi Sesha Giri Jagarapu was first appointed on 22 Jun 2020 as Director at Ojas Pharmaceuticals Private Limited. The most recent appointment on record is 18 Dec 2023 at Honour Lab Limited.

The 2 current companies of Adi Sesha Giri Jagarapu that report revenue have a combined latest revenue of ₹5,807 Cr: Hetero Drugs Limited ₹3,324 Cr (FY 2025); Honour Lab Limited ₹2,483 Cr (FY 2025).

Adi Sesha Giri Jagarapu held 1 earlier board appointment: Degradable Polymer Technologies Private Limited (Additional Director, 22 Jun 2020 to 03 Sep 2021).

The current boards of Adi Sesha Giri Jagarapu's companies include Bandi Vamsikrishna (Hetero Drugs Limited), Gopal Reddy Annareddy (Hetero Drugs Limited), Kalavathi Bandi (Hetero Drugs Limited), Kaza Sai Venkata Sharath Krishna (Hetero Drugs Limited), Parthasaradhi Reddy Bandi (Hetero Drugs Limited), Sambi Reddy Jonnala (Hetero Drugs Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available